On Wednesday shares of XBiotech Inc (NASDAQ:XBIT) closed at $23.25. XBiotech Inc (NASDAQ:XBIT) said that, it has taken its mission to develop drugs from naturally occurring monoclonal antibodies to the public markets. The company sold 4 million shares at $19 a piece, in the middle of its expected range, to raise $76 million.
On last trading day Pfizer Inc. (NYSE:PFE) moved up 0.51% to close at $35.21. Its volatility for the week is 1.45% while volatility for the month is 1.52%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is 2.24%. On 9 April, Pfizer Inc. (NYSE:PFE) said that, BIND Therapeutics, Inc has extended the terms of its global collaboration with Pfizer Inc. PFE to create Accurins that optimize the therapeutic potential of two molecularly targeted oncology drugs in Pfizer’s pipeline.
On last trading day Applied Genetic Technologies Corporation (NASDAQ:AGTC) decreased -2.46% to close at $22.16. Its volatility for the week is 2.91% while volatility for the month is 4.65%. Applied Genetic Technologies Corporation (NASDAQ:AGTC) monthly performance is -2.51%. Cantor Fitzgerald restated their buy rating on shares of Applied Genetic Technologies Corporation (NASDAQ:AGTC) in a report issued on Thursday. They currently have a $28.00 target price on the stock.
Tsakos Energy Navigation Limited (NYSE:TNP) has 18.83% insider ownership while its institutional ownership stands at 45.40%. In last trading activity company’s stock closed at $9.16. Tsakos Energy Navigation Limited (NYSE:TNP) announced that its Board of Directors declared regular quarterly cash dividends of $0.50 per share for its 8.00% Series B Cumulative Redeemable Perpetual Preferred Shares (the “Series B Preferred Shares”) (NYSE: TNPPRB) and $0.5547 per share for its 8.875% Series C Cumulative Redeemable Perpetual Preferred Shares (the “Series C Preferred Shares”) (NYSE: TNPPRC). Each dividend is for the period from the most recent dividend payment date on January 30, 2015 through April 29, 2015.
On Wednesday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $18.58. Epizyme, Inc. (NASDAQ:EPZM) announced that data from its preclinical pipeline will be presented during the American Association for Cancer Research (AACR) Annual Meeting, to be held April 18-25 in Philadelphia, Pa.